Hemerus Medical, LLC designs and develops novel blood collection, storage, and preservation technologies to improve and extend the shelf life of blood and blood products. These technologies are intended to improve patient transfusion outcomes and to ensure high-quality life-saving blood products are available to all patients when and where they are needed the most. Our technologies are designed as a platform to enable other technologies to foster, grow, and improve patients’ lives.
Hemerus' advanced technologies include LEUKOWEB™ leukocyte reduction media, LEUKOSEP™ leukoreduction filters, LEUP™ processing circuits, and our next generation of anticoagulants and additive solutions for Red Blood Cells (RBC) and Whole Blood (WB):
* Currently SOLX™ RBCs are indicated for up to 42 days of storage in the United States.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.